Myra Teasley
Raleigh, NCNPI 1013977636
Payments from drug & device makers
Across 75 payments — averaging $15.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Therapeuticsmd, Inc.$236
- Bayer$140
- Duchesnay USA Incorporated$121
- AbbVie$113
- Astellas Pharma US Inc$87
- Merck$70
- plus $390 from 13 others
What the payments were for
- Food & beverage$1,11997%
- Education$383%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Therapeuticsmd, Inc. | 12 | $236 |
| Bayer | 10 | $140 |
| Duchesnay USA Incorporated | 11 | $121 |
| AbbVie(2 entities) | 8 | $113 |
| Astellas Pharma US Inc | 5 | $87 |
| Merck | 4 | $70 |
| Daiichi Sankyo Inc. | 4 | $64 |
| Coopersurgical, Inc. | 1 | $52 |
| Lupin Inc. | 4 | $50 |
| Vertical Pharmaceuticals, LLC | 3 | $44 |
| Zyla Life Sciences, Inc. | 3 | $40 |
| Roche Diagnostics Corporation | 1 | $25 |
| Pfizer | 2 | $23 |
| Mylan Pharmaceuticals Inc. | 2 | $23 |
| Hologic Sales And Service, LLC | 1 | $17 |
| Amgen | 1 | $16 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
| Boston Scientific | 1 | $12 |
| Meditrina | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BIJUVA$103
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.